See other companies on Welcome to the Jungle

Glooko

Application for diabetes management

Glooko logo
201-500 employees
  • Healthcare
  • B2B
  • SaaS
Downtown North, Palo Alto, CA

Company mission

To enhance the lives of people with chronic conditions by connecting them with their caregivers and equipping both with the tools needed to achieve positive outcomes.

Top investors

Few candidates hear
back within 2 weeks

-4% employee growth in 12 months

Our take

Glooko is a Software-as-a-Service provider that offers diabetes patients and healthcare providers important data. Glooko leverages evolving diabetes information in order to improve patient outcomes and provider access to data, while reducing related costs.

Among the services provided by the company are a patient mobile app, a provider population management app, and a meter sync hardware device. This latter innovation offers both insights on patients’ conditions and an array of population management features.

Glooko is just one of many companies competing in the telehealth environment, with Epic, Cerner, WebPT, eClinicalWorks, and Kareo among the businesses delivering similar services. However, Glooko promises to usurp the competition by offering superior coverage and the ability to sync in real-time with diabetes devices, fitness, and biometric services. Glooko's MedTech and IoT partners include companies Sanofi and Senseonics among other international MedTech brands.

Freddie headshot

Freddie

Company Specialist at Welcome to the Jungle

Company values

  • Trustworthy
  • Dedicated
  • Collaborative
  • Innovative
  • People-centered

Funding (last 2 of 8 rounds)

Oct 2024

$100m

SERIES F

Mar 2021

$30m

SERIES D

Total funding: $202.9m

This company has top investors

Leadership

Yogen Dalal

(Investor & Board Member)

PhD in Electrical Engineering at Stanford. Co-founder, VP Product Development at Claris. Managing Director at Mayfield Fund. Co-founded Glooko in 2010. Recognised as key figure in founding of internet.